US-based pharmaceutical giant Eli Lilly has launched its diabetes and weight-loss drug, Mounjaro, in India, following approval from the Central Drugs Standard Control Organisation (CDSCO).

The new class of weight-loss medicines that has taken the world by a storm will now become available in India, with the pharmaceutical giant Eli Lilly on Thursday announcing the launch of tirzepatide ...

Eli Lilly and Company launched its weight loss drug Mounjaro in India on Thursday after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO). This is a drug which ...

“Semaglutide generics will be priced almost 95% lower than [Eli Lilly'] current price,” said Vishal Manchanda, senior vice-president, institutional research at Systematix Group. With the drop ...

US pharma major Eli Lilly on Thursday launched the much-awaited diabetes and obesity management drug Mounjaro in India at one-fifth of US price. Lilly launched the drug in a single dose vial following ...

The following is the full text of the March 20, 2025 address by former hostage Eli Sharabi at the UN Security Council in New York City. My name is Eli Sharabi. I am 53 years old. I’ve come ...

Eli Lilly has launched its blockbuster diabetes and weight-loss drug Mounjaro in India following approval from the country’s drug regulator, it said on Thursday. Global demand for Lilly’s diabetes and ...

MNC pharma major Eli Lilly has launched Mounjaro (tirzepatide), a weekly injection for obesity and type 2 diabetes, after obtaining approval from India’s Central Drugs Standard Control ...

The much-awaited weightloss and diabetes drug, Mounjaro from US-based Eli Lilly and Company will be available at local chemists in a few weeks, at an India-specific price. Globally Mounjaro ...

Follow Bloomberg India on WhatsApp for exclusive content and analysis on what billionaires, businesses and markets are doing. Sign up here. Eli Lilly and Co. has begun selling its blockbuster ...

Eli Lilly stock has generated fantastic returns for investors over the past five years. The company possesses many lucrative growth opportunities to ensure it remains an excellent buy in the years ...

The session opened with testimony from Eli Sharabi, a survivor of Hamas captivity, who shared his account at a press conference and with the Council members during the session. "On October 7 ...